Surge in drug price won’t pose threat to heroin overdose patients in Washington

  • Source: Spokane Spokesman-Review
  • Published: 02/15/2017 05:25 PM

A dramatic price increase for one form of an opioid overdose reversal drug has some people concerned, but Washington health and law enforcement agencies said it’s not affecting their ability to provide care. Last week, Washington Sen. Maria Cantwell joined 30 Democratic colleagues to sign a letter demanding answers from Kaleo Pharmaceuticals, which manufacturers an auto-injector form of naloxone. Naloxone is a generic drug that reverses opioid overdoses. The drug has risen from $690 in 2014 to $4,500 this year, according to the letter. The drug manufacturer has disputed that price. The letter prompted widespread coverage of the price boost in USA Today, Scientific American, Wired and other sources, with many articles comparing it to the well-publicized price hike of the Epi-Pen last year.


We welcome comments from registered users. Comments are solely the responsibility of those who post them; their viewpoints are not endorsed by the Daily Dispatch and (read more)
ship name
no comments have been added

Sign up to subscribe to custom state Daily Dispatch emails for free

click to subscribe